‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development

Dimitrios C. Mastellos; Anna M. Blom; E. Sander Connolly; Mohamed R. Daha; Brian V. Geisbrecht; Berhane Ghebrehiwet; Piet Gros; George Hajishengallis; V. Michael Holers; Markus Huber‐Lang; Taroh Kinoshita; Tom Eirik Mollnes; Robert A. Montgomery; B. Paul Morgan; Bo Nilsson; Rubén Pı́o; Daniel Ricklin; Antonio M. Risitano; Ronald P. Taylor; Alberto Mantovani; John P A Ioannidis; John D. Lambris

doi:10.1038/s41590-019-0503-1

Related publications

Corrigendum2019

Author Correction: ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development

Dimitrios C. Mastellos, Anna M. Blom, E. Sander Connolly, Mohamed R. Daha, Brian V. Geisbrecht, Berhane Ghebrehiwet, Piet Gros, George Hajishengallis, V. Michael Holers, Markus Huber‐Lang, Taroh Kinoshita, Tom Eirik Mollnes, Robert A. Montgomery, B. Paul Morgan, Bo Nilsson, Rubén Pı́o, Daniel Ricklin, Antonio M. Risitano, Ronald P. Taylor, Alberto Mantovani, John P A Ioannidis, John D. Lambris

Article2022

Gene Therapy: An emerging therapeutic approach

Sravan Kumar Pasumarthi, Amit Khurana, Ralf Weiskirchen

Article2021

Mitochondria-targeted nanoparticles (mitoNANO): An emerging therapeutic shortcut for cancer

Tanveer A. Tabish, Michael R Hamblin

Article2021

Microplastics as an emerging threat to plant and soil health in agroecosystems

Jie Zhou, Yuan Wen, Miles R. Marshall, Zhaohai Zeng, Heng Gui, Yadong Yang, Zhaohai Zeng, Davey L Jones, Huadong Zang

The Science of The Total Environment

Article1991

New Organizational Forms for Enhancing Innovation: The Case of Internal Corporate Joint Ventures

Edward J. Zajac, Brian Golden, Stephen M Shortell